Long-term safety of twice-daily aclidinium bromide in COPD patients: A one-year, double-blind study

被引：0
|
作者：
Gelb, Arthur [1 ]
Tashkin, Donald [2 ]
Make, Barry [3 ]
Zhong, Xiaoyun [4 ]
Gil, Esther Garcia [5 ]
Caracta, Cynthia [6 ]
机构：
[1] Southern Calif Clin Trials, Lakewood, CO USA
[2] UCLA, Div Pulm & Crit Care Med, David Geffen Sch Med, Los Angeles, CA USA
[3] Natl Jewish Hlth, Dept Med, Denver, CO USA
[4] Forest Res Inst, Biostat, Jersey City, NJ USA
[5] Almirall SA, R&D Ctr, Barcelona, Spain
[6] Forest Res Inst, Clin Dev, Jersey City, NJ USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
COPD; -; management; Bronchodilators; Exacerbation;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3536
引用
收藏
页数：1
相关论文
共 50 条
  • [21] ACCORD COPD II: A Randomized Clinical Trial to Evaluate the 12-Week Efficacy and Safety of Twice-Daily Aclidinium Bromide in Chronic Obstructive Pulmonary Disease Patients
    Rennard, Stephen I.
    Scanlon, Paul D.
    Ferguson, Gary T.
    Rekeda, Ludmyla
    Maurer, Brian T.
    Garcia Gil, Esther
    Caracta, Cynthia F.
    CLINICAL DRUG INVESTIGATION, 2013, 33 (12) : 893 - 904
  • [22] Twice-Daily Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination: Lung Function Improvements In The Augment COPD Trial In Patients With Moderate To Severe COPD
    D'Urzo, A. D.
    Rennard, S. I.
    Kerwin, E. M.
    Mergel, V.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [23] Long-term safety and antianginal efficacy of the If current inhibitor ivabradine in patients with chronic stable angina. A one-year randomised, double-blind, multicentre trial
    Lopez-Bescos, L
    Fillpova, S
    Martos, R
    EUROPEAN HEART JOURNAL, 2004, 25 : 138 - 138
  • [24] A multicenter double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesteremia
    Dart, A
    Jerums, G
    Nicholson, G
    dEmden, M
    HamiltonCraig, I
    Tallis, G
    Best, J
    West, M
    Sullivan, D
    Bracs, P
    Black, D
    PERFUSION, 1997, 10 (09): : 296 - +
  • [25] A multicenter, double-blind, one-year study comparing safety and efficacy of Atorvastatin versus Simvastatin in patients with hypercholesterolemia
    Dart, A
    Jerums, G
    Nicholson, G
    dEmden, M
    HamiltonCraig, I
    Tallis, G
    Best, J
    West, M
    Sullivan, D
    Bracs, P
    Black, D
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (01): : 39 - 44
  • [26] Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease
    Jones, Roy W.
    Bayer, Antony
    Inglis, Fraser
    Barker, Andrew
    Phul, Ravinder
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 22 (03) : 258 - 262
  • [27] Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD
    Donohue, James F.
    Soong, Weily
    Wu, Xiao
    Shrestha, Pomy
    Lei, Alejhandra
    RESPIRATORY MEDICINE, 2016, 116 : 41 - 48
  • [28] Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: A pharmacokinetic and long-term safety study
    Beerepoot, LV
    Witteveen, EO
    Groenewegen, G
    Fogler, WE
    Sim, BKL
    Sidor, C
    Zonnenberg, BA
    Schramel, F
    Gebbink, MFBG
    Voest, EE
    CLINICAL CANCER RESEARCH, 2003, 9 (11) : 4025 - 4033
  • [29] Once-versus twice-daily venlafaxine therapy in major depression: A randomized, double-blind study
    Amsterdam, JD
    Hooper, MB
    Amchin, J
    JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (05) : 236 - 240
  • [30] One-year efficacy of aclidinium/formoterol fixed-dose combination in COPD patients: The AUGMENT COPD study
    D'Urzo, Anthony
    Rennard, Stephen
    Kerwin, Edward
    Mergel, Victor
    He, Thomas
    Leselbaum, Anne
    Caracta, Cynthia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345